ArticleActa psychiatrica Scandinavica2026
The Bergen 4-Day OCD Treatment: A Comprehensive Scoping Review of Evidence and Implementation.
Article in Acta psychiatrica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Considering Access and Methodological Rigor in Framing Results of the Bergen 4 Day Treatment Program for Obsessive-Compulsive Disorder.Acta psychiatrica Scandinavica · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObsessive-compulsive disorder (OCD) affects 1%-3% of the population, significantly impairing daily functioning and quality of life. Traditional treatments, including cognitive behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs), often face implementation challenges.
aimThis scoping review explores the efficacy and effectiveness of the Bergen 4-Day OCD Treatment (B4DT) across various populations and clinical settings.
methodA systematic search was conducted for studies published between 2005 and 2025, focusing on the B4DT's outcomes, patient satisfaction, and treatment acceptability. The PCC framework guided the development of the inclusion and exclusion criteria.
resultsTwelve studies met the inclusion criteria, demonstrating a reduction in OCD symptoms, high response and remission rates, and strong patient satisfaction. Long-term follow-up indicated durable treatment effects, with minimal relapse.
conclusionThe Bergen 4-Day Treatment is a viable frontline option for OCD management, warranting further research to optimize its implementation across diverse healthcare systems. Future studies should focus on enhancing patient adherence and expanding the treatment's applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.